Category Archives: Companies

RNAi Therapeutics Targeting ALAS-1 Completely Block Production of Toxic Heme Biosynthesis Intermediates that Cause Symptoms and Disease Pathology CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 17, 2013-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi therapeutic program targeting aminolevulinate...

Tekmira Announces Election of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 15, 2013-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2013 UBS Global Healthcare Conference on Wednesday, May 22, 2013 at 8:00 a.m. ET at The Sheraton New York Hotel in New York City....

Tekmira Presents LNP Technology Innovations at Scientific Symposium

Tekmira Provides Corporate Update and Announces First Quarter 2013 Results

Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 8, 2013-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2013 Bank of America Merrill Lynch Health Care Conference on Thursday, May 16, 2013 at 8:40 a.m. PT (11:40 a.m. ET) at Encore at...

Tekmira Provides Update on U.S. Government Sponsored TKM-Ebola Program

Continued to Execute on Alnylam 5x15 Product Strategy, Positioning Company for Data-Rich Period over Next Several Months Formed Strategic Alliance with The Medicines Company to Develop and Commercialize ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Hypercholesterolemia Completed Successful Public Offering of Stock; Maintained Strong Balance Sheet with...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 29, 2013-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the first quarter ending March 31, 2013 on Monday, May 6, 2013, after the U.S. financial markets close. Management will provide an update on the company,...